why choose us

First received: November 15, 2022

Clinical Trial: Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Inflammatory Bowel Diseases

Study Type: OBSERVATIONAL


Official Title: Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD

Brief Summary: Investigators propose to validate efficacy and safety of the detection of DEFA5 in the diagnosis of the colonic IBD using longitudinal vs. cross-sectional studies of known patient clinical data to correlate with their endoscopy biopsy data.30% of colonic IBD patients cannot be accurately diagnosed (CC vs. UC) in a timely manner even when a state-of-the-art classification system of combined clinical, endoscopic, radiologic and histologic tools are used.When the diagnostic classification for these two diseases is…

Read more